4893 items matching your search terms.

Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy

Olver, I. N. Grimison, P. Chatfield, M. Stockler, M. R. Toner, G. C. Gebski, V. Harrup, R. Underhill, C. Kichenadasse, G. Singhal, N. Davis, I. D. Boland, A. McDonald, A. Thomson, D. B. for the Australian and New Zealand Urogenital and Prostate Cancer Trials Group,
SUPPORTIVE CARE IN CANCER, 2013     DOI:10.1007/s00520-012-1696-0

Forming networks for research: proposal for an Australian clinical trials alliance

Olver, I.N. Keech, A.C.
MEDICAL JOURNAL OF AUSTRALIA, 2013     DOI:10.5694/mja12.11067.

Feasibility of adjacent insulin infusion and continuous glucose monitoring via the Medtronic Combo-set

O'Neal, D.N. Adhya, S. Jenkins, A. Ward, G. Welsh, J.B. Voskanyan, G.

Robot-assisted hysterectomy compared to open and laparoscopic approaches: systematic review and meta-analysis

O'Neill, M. Moran, P.S. Teljeur, C. O'Sullivan, O.E. O'Reilly, B.A. Hewitt, M. Flattery, M. Ryan, M.

Clinical prediction models for bronchopulmonary dysplasia: a systematic review and external validation study

Onland, W. Debray, T. P. Laughon, M. M. Miedema, M. Cools, F. Askie, L. M. Asselin, J. M. Calvert, S. A. Courtney, S. E. Dani, C. Durand, D. J. Marlow, N. Peacock, J. L. Pillow, J. J. Soll, R. F. Thome, U. H. Truffert, P. Schreiber, M. D. Van Reempts, P. Vendettuoli, V. Vento, G. van Kaam, A. H. Moons, K. G. Offringa, M.
BMC PEDIATRICS, 2013     DOI:10.1186/1471-2431-13-207

The association of skin intrinsic fluorescence with type 1 diabetes complications in the DCCT/EDIC study

Orchard, T. J. Lyons, T. J. Cleary, P. A. Braffett, B. H. Maynard, J. Cowie, C. Gubitosi-Klug, R. A. Way, J. Anderson, K. Barnie, A. Villavicencio, S. DCCT/EDIC Research Group,
DIABETES CARE, 2013     DOI:10.2337/dc12-2661

ICON7: final overall survival results in the GCIG phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer

Oza, AM Perren, TJ Swart, AM Schröder, W Pujade-Lauraine, E Havsteen, H Beale, P Cervantes, AM Embleton, AC Parmar, M

Caring for women with ovarian cancer in the last year of their life: impact on the caregiver

Butow. P Price, M Bell, M Webb, P DeFazio, A Australian Ovarian Cancer Study Group, Australian Ovarian Cancer Study Quality of Life Study Investigators Friedlander, M

Antiplatelet agents for chronic kidney disease

Palmer, S. C. Di Micco, L. Razavian, M. Craig, J. C. Perkovic, V. Pellegrini, F. Jardine, M. J. Webster, A. C. Zoungas, S. Strippoli, G. F.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013     DOI:10.1002/14651858.CD008834.pub2

Antiplatelet therapy to prevent hemodialysis vascular access failure: systematic review and meta-analysis

Palmer, S. C. Di Micco, L. Razavian, M. Craig, J. C. Ravani, P. Perkovic, V. Tognoni, G. Graziano, G. Jardine, M. Pellegrini, F. Nicolucci, A. Webster, A. Strippoli, G. F.
AMERICAN JOURNAL OF KIDNEY DISEASES, 2013     DOI:10.1053/j.ajkd.2012.08.031

INTEGRATE: A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced esophagogastric cancer—a study by the Australasian Gastrointestinal Trials Group (AGITG).

Pavlakis, M Goldstein, D Sjoquist, KM Martin, A Tsobanis, E Yip, S Shannon, J Burge, ME Cronk, MF Tebbutt, NC Strickland, A Lipton, LR Price, TJ Nott, LM Harris, DL Burnell, MJ Alcindor, T Bang, YJ Kang, YK O'Callaghan, CJ

Partial and complete retirement due to ill-health among mature age Australians

Pit, S.W. Shrestha, R. Schofield, D. Passey, M.
PUBLIC HEALTH, 2013     DOI:10.1016/j.puhe.2012.12.022

Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: a prospective population-based study over the last year of life

Price, M.A. Bell, M.L. Sommeijer, D.W. Friedlander, M. Stockler, M.R. Defazio, A. Webb, P.M. Australian Ovarian Cancer Study Group, Australian Ovarian Cancer Study Quality of Life Study Investigators, Butow, P.N.
GYNECOLOGIC ONCOLOGY, 2013     DOI:10.1016/j.ygyno.2013.03.031

Can we accurately report PTEN status in advanced colorectal cancer?

Price, T Hocking, C Broadbridge, V Wrin, J Townsend, AR Tebbutt, N Cooper, J Ruszkiewicz, A Lee, C Hardingham, J

Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer receiving bevacizumab

Price, T. J. Hardingham, J. E. Lee, C. K. Townsend, A. R. Wrin, J. W. Wilson, K. Weickhardt, A. Simes, R. J. Murone, C. Tebbutt, N. C.
CANCER MEDICINE, 2013     DOI:10.1002/cam4.75